30 May 2024
Cancers | Highly Cited Special Issues in 2022–2023 Related to Molecular Cancer Biology


We are pleased to invite you to read the highly cited Special Issues in 2022 and 2023 related to molecular cancer biology in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant Special Issues is provided below:

Novel Biomarkers and Molecular Targets in Cancer
Guest Editor:  Dr. Anna Kakehashi
Views: 124000+ | Cited by 430+

Incorporating DNA Damage Response (DDR) Mechanisms in Cancer Systems
Guest Editor: Prof. Dr. Alexandros Georgakilas
Views: 89000+ | Cited by 380+

Hippo Signaling Pathway in Cancers
Guest Editor: Dr. Joachim Kremerskothen
Views: 38000+ | Cited by 170+

Updates on Molecular Targeted Therapies for CNS Tumors
Guest Editor: Dr. Edward Pan
Views: 54000+ | Cited by 150+

Thyroid Cancers
Guest Editor: Prof. Vincenzo Marotta
Views: 31000+ | Cited by 110+

Molecular Pathogenesis of Cervical Cancer
Guest Editor: Dr. Thilo Dörk
Views: 56000+ | Cited by 120+

Breast Cancer: Novel Histological and Molecular Markers for Diagnosis, Prognosis, Therapeutic Prediction, and Drug Resistance
Guest Editors: Dr. Maurizio Di Bonito, Prof. Dr. Michelino De Laurentiis and Dr. Monica Cantile
Views: 93000+ | Cited by 200+

Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients. A Selection of Papers from the Third Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
Guest Editor: Prof. Dr. Paul Hofman, Prof. Dr. George A. Calin, Dr. Ignacio I. Wistuba and Prof. Dr. Sendurai A. Mani
Views: 48000+ | Cited by 170+

You are invited to view and submit relevant papers and proposals for some related Special Issues to the journal Cancers at the following links:

 Cancers Editorial Office

Back to TopTop